Skip to main content

Select Drug Profiles

Perspectives, Health Policy and Reform

The Health Reform in America

Uwe Reinhardt, PhD

Practice Management

Medicare Coverage Policies for Biologics: The Broad Gray Line

Stakeholder Perspective

CMS Coverage Policies for Biologics: Defining a Lagrangian Point for Cost, Quality, and Access

by Michael F. Murphy, MD, PhD

Practice Management

Benchmarking New Frontiers in Managed Care Pharmacy

Cynthia Pigg, BSPharm, MHA , Joan Cihak, MSS, MHA

Stakeholder Perspective

Emerging Trends in Managed Care Pharmacy: Familiar Gaps but Great Potentials

by F. Randy Vogenberg, PhD, FASHP

Practice Management

Not Waiting for Godot: The Evolution of Health Promotion at PPG Industries

Alberto M. Colombi, MD, MPH, Janice L. Pringle, PhD, George T. Welsh, BS, MBA

Stakeholder Perspective

The Evolution of Health Promotion by Employers

by F. Randy Vogenberg, PhD, FASHP

Original Research

Meta-Analysis 101: What You Want to Know in the Era of Comparative Effectiveness

J. B. Jones, PhD, MBA, Saul Blecker, MD, Nirav R. Shah, MD,MPH

Stakeholder Perspective

Meta-Analyses and Patient Care

by Scott R. Taylor, RPh, MBA

Original Research

Depression Overview

Thomas McCarter, MD, FACP

Practice Management

Seizing the Opportunity

Gary M. Owens, MD

Regulatory Concerns Fuel Hunger in Congress for FDA Reform

Avoiding the Unthinkable: A Tale of 2 Triangles and the Process of Care They Govern

Robert E. Henry

The Unbearable Laughs of Mental Health

Alberto M. Colombi, MD, MPH

Page 229 of 244
Results 2281 - 2290 of 2434